Almost half of all European patent applications came from the EPO member states, followed by the US, Japan, China and South Korea. Applications from Europe were on a par with last year, with marked differences among individual countries. Europe’s growth champions were Belgium and Italy. More modest rises came from Austria, Spain, Switzerland and the UK. Demand from Europe’s biggest patent applicant, Germany, was stable, while France, the Netherlands and many of the Nordic countries filed fewer applications. Overall, China (and to a lesser extent South Korea) was the main driver of growth in applications at the EPO. Applications from the US dropped considerably (although this was only a correction after the one-off jump in 2015 resulting from a change in US patent law), while Japanese companies filed slightly fewer applications.
Anadrole is named after the compound – anadrol. Another immensely powerful bulking steroid that can bring about huge increases in weight. This rapid weight gain is due to the body adding muscle and water. Because it can cause the body to retain a considerable amount of fluid, it can leave a user looking more smooth compared to other ‘dry’ steroids. Anadrol is also thought to be more toxic than other steroids, hence how bodybuilders often prefer dianabol instead. Obviously, anadrole will be much less toxic on the body and safe to use in comparison.